All Omicron subvariants can reduce vaccine protection
Scientists from Columbia University found only one currently authorized antibody treatment retains its activity against all Omicron subvariants.
They also found that the effectiveness of...
Drugs for common bowel disease may prevent severe COVID-19
Scientists from Cedars-Sinai found that medicine for inflammatory bowel disease may protect against severe COVID-19.
The research is published in IBD, and Frontiers in Immunology and...
These people more likely to have breakthrough COVID infections
Scientists from Case Western Reserve University found that breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are significantly more likely in cancer and...
Omicron BA.2 does not cause more severe illness than BA.1
Scientists from the University of Wisconsin–Madison found that the BA.2 subvariant of omicron is similar to BA.1 in both the severity of illness it...
Scientists finds who is most at risk to get long COVID
Scientists from Hiroshima University found that having a mild case of COVID-19, smoking status, comorbidities, or your gender aren't significant predictors to tell if...
This study shows the cause of severe inflammation in COVID-19
Clinical evidence showed that the leading cause of death in COVID-19 patients is the dangerous condition known as a cytokine storm.
Scientists from the University...
COVID-19 leads to high blood clot risk
Scientists from the University of Oxford found that around 1 in 100 people with COVID-19 developed dangerous blood clots, with rates higher in men,...
‘Natural immunity’ from COVID-19 omicron is weak and limited
Scientists from Gladstone Institutes and UC San Francisco found that in unvaccinated people, infection with the omicron variant of COVID-19 provides little long-term immunity...
Increasing urban greenery could have prevented 34,000 US deaths in the past 20 years
Scientists from Boston University found that increasing greenery in US urban areas may substantially reduce death.
They found that increasing green vegetation in large, metropolitan...
This drug could benefit people with severe COVID-19
Scientists from Amsterdam University Medical Centers found that patients with severe COVID-19 who were given imatinib had lower death risk at 90-day follow-up.
The research...